Expanding RNA Druggability with Small Molecules
The 3rd RNA- Targeted Drug Discovery Summit returns as the most comprehensive and definitive event for the RNA targeting small molecule community to not only address key challenges of the field, such as successful determination and prediction of RNA structure and role in disease, but also to drive forward optimized strategies to improve target selection and gain pre-clinical proof of concept to drive the field forward towards translation into clinical development.
With numerous approaches emerging to demonstrate genuine viability in directly or indirectly targeting RNA with small molecules, join leading biopharmaceutical directors, VPs and C-level executives at the 3rd RNA- Targeted Drug Discovery Summit – your premier industry and translational focused conference dedicated to advancing pioneering RNA biology and drug discovery into a blockbuster RNA targeting small molecule therapeutic approach that improves patient outcomes.
Expert Speakers at the RNA- Targeted Drug Discovery Summit Include:
Professor, Department of Chemistry & Neuroscience
The Scripps Research Institute & Scientific Founder of Expansion Therapeutics
Chief Scientific Officer
Founder and Chief Scientific Officer
Pyle Sterling Professor
Yale University & HHMI Investigator